SUSTAINED DRUG RELEASE COMPOSITION

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160361262A1
SERIAL NO

15093468

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a sustained release formulation for delivering one or more pharmaceutically active agents. The formulation comprises cross-linked high amylose starch and at least one pharmaceutically active agent, and optionally can be subdivided into smaller dosage forms where the smaller dosage forms have substantially the same sustained release properties as the formulation from which they were derived. The formulations can provide sustained release for up to at least 24 hours, and because of their divisability permits a recipient of the active agent or the person administering the active agent to titrate the dosage of the agent.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ANGELINI PHARMA INCROCKVILLE MD 20850

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Contamin, Pauline Magny En Vexin, FR 13 90
Gervais, Sonia Laval, CA 28 444
Ma, My Linh Saint-Laurent, CA 8 77
Ouzerourou, Rachid Anjou, CA 11 190
Smith, Damon Saint-Laurent, CA 54 503

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation